Role of the SIK2–p35–PJA2 complex in pancreatic β-cell functional compensation
暂无分享,去创建一个
A. Gingras | N. Bardeesy | S. Baird | J. Sakamaki | R. Screaton | Accalia Fu | S. Yee | Courtney Reeks | C. Depatie | Mufida Al Azzabi
[1] A. Dobrzyń,et al. Islet β-cell failure in type 2 diabetes--Within the network of toxic lipids. , 2015, Biochemical and biophysical research communications.
[2] J. Sanes,et al. SAD-A kinase controls islet β-cell size and function as a mediator of mTORC1 signaling , 2013, Proceedings of the National Academy of Sciences.
[3] R. Screaton,et al. CRTC2 is required for β-cell function and proliferation. , 2013, Endocrinology.
[4] R. Screaton,et al. Role of AMPK in pancreatic beta cell function , 2013, Molecular and Cellular Endocrinology.
[5] Rebecca E. Saunders,et al. Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila , 2012, Nature Cell Biology.
[6] Angela N. Brooks,et al. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing , 2012, Cell.
[7] Amber L. Couzens,et al. Mass spectrometry approaches to study mammalian kinase and phosphatase associated proteins. , 2012, Methods.
[8] N. Ip,et al. Cdk5: a multifaceted kinase in neurodegenerative diseases. , 2012, Trends in cell biology.
[9] E. Oetjen. Antidiabetic actions of a non–agonist PPARγ ligand blocking Cdk5–mediated phosphorylation , 2012 .
[10] G. Aguilera,et al. Salt-inducible kinase is involved in the regulation of corticotropin-releasing hormone transcription in hypothalamic neurons in rats. , 2012, Endocrinology.
[11] L. Tsai,et al. Cyclin-dependent kinases in brain development and disease. , 2011, Annual review of cell and developmental biology.
[12] M. Prentki,et al. Type 2 diabetes across generations: from pathophysiology to prevention and management , 2011, The Lancet.
[13] Tadao Shibasaki,et al. Dynamics of insulin secretion and the clinical implications for obesity and diabetes. , 2011, The Journal of clinical investigation.
[14] John B. Thomas,et al. A Hormone-Dependent Module Regulating Energy Balance , 2011, Cell.
[15] L. Annunziato,et al. Control of PKA stability and signalling by the RING ligase praja2 , 2011, Nature Cell Biology.
[16] S. Sakoda,et al. SIK2 Is a Key Regulator for Neuronal Survival after Ischemia via TORC1-CREB , 2011, Neuron.
[17] Jongkyeong Chung,et al. Drosophila Salt-inducible Kinase (SIK) Regulates Starvation Resistance through cAMP-response Element-binding Protein (CREB)-regulated Transcription Coactivator (CRTC)* , 2010, The Journal of Biological Chemistry.
[18] K. Kitagawa,et al. Downregulation of SIK2 expression promotes the melanogenic program in mice , 2010, Pigment cell & melanoma research.
[19] J. Girard,et al. Salt-inducible kinase 2 links transcriptional coactivator p300 phosphorylation to the prevention of ChREBP-dependent hepatic steatosis in mice. , 2010, The Journal of clinical investigation.
[20] Failure of islet β‐cell compensation for insulin resistance causes type 2 diabetes: What causes non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis? , 2010, Journal of gastroenterology and hepatology.
[21] Tony Pawson,et al. ProHits: an integrated software platform for mass spectrometry-based interaction proteomics , 2010, Nature Biotechnology.
[22] R. Bast,et al. SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer. , 2010, Cancer cell.
[23] A. Rosenwald,et al. Amplification at 11q23 targets protein kinase SIK2 in diffuse large B-cell lymphoma , 2010, Leukemia & lymphoma.
[24] G. Rutter,et al. LKB1 deletion with the RIP2.Cre transgene modifies pancreatic β-cell morphology and enhances insulin secretion in vivo , 2010, American journal of physiology. Endocrinology and metabolism.
[25] M. Laakso,et al. Impaired beta cell glucose sensitivity rather than inadequate compensation for insulin resistance is the dominant defect in glucose intolerance , 2010, Diabetologia.
[26] M. Lombès,et al. Involvement of SIK2/TORC2 signaling cascade in the regulation of insulin-induced PGC-1alpha and UCP-1 gene expression in brown adipocytes. , 2009, American journal of physiology. Endocrinology and metabolism.
[27] J. Vandekerckhove,et al. The atypical kinase Cdk5 is activated by insulin, regulates the association between GLUT4 and E-Syt1, and modulates glucose transport in 3T3-L1 adipocytes , 2009, Proceedings of the National Academy of Sciences.
[28] R. Screaton,et al. Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2 , 2008, Proceedings of the National Academy of Sciences.
[29] J. Florez. Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: Where are the insulin resistance genes? , 2008, Diabetologia.
[30] John B. Thomas,et al. The insulin-regulated CREB coactivator TORC promotes stress resistance in Drosophila. , 2008, Cell metabolism.
[31] L. Brennan,et al. Amino acid metabolism, insulin secretion and diabetes. , 2007, Biochemical Society transactions.
[32] J. Yates,et al. Insulin modulates gluconeogenesis by inhibition of the coactivator TORC2. , 2007, Nature.
[33] M. Prentki,et al. Islet beta cell failure in type 2 diabetes. , 2006, The Journal of clinical investigation.
[34] K. Mikoshiba,et al. Cdk5-dependent regulation of glucose-stimulated insulin secretion , 2005, Nature Medicine.
[35] J. Yates,et al. The CREB Coactivator TORC2 Functions as a Calcium- and cAMP-Sensitive Coincidence Detector , 2004, Cell.
[36] John Calvin Reed,et al. cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2 , 2003 .
[37] S. Kahn,et al. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes , 2003, Diabetologia.
[38] Xueying Lin,et al. cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. , 2003, Genes & development.
[39] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[40] R. Nusse,et al. Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes , 2002, Science.
[41] C. Bogardus,et al. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.
[42] M. Okamoto,et al. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet‐treated rat adrenal1 , 1999, FEBS letters.
[43] L. Tsai,et al. p35, the Neuronal-specific Activator of Cyclin-dependent Kinase 5 (Cdk5) Is Degraded by the Ubiquitin-Proteasome Pathway* , 1998, The Journal of Biological Chemistry.
[44] M. Byrne,et al. Elevated plasma glucose 2 h postchallenge predicts defects in beta-cell function. , 1996, The American journal of physiology.
[45] O. Ohara,et al. A novel RING-H2 motif protein downregulated by axotomy: its characteristic localization at the postsynaptic density of axosomatic synapse , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[46] C. Newgard,et al. Metabolic coupling factors in pancreatic beta-cell signal transduction. , 1995, Annual review of biochemistry.
[47] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.
[48] M. Maffei,et al. Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.
[49] R. Aebersold,et al. A brain-specific activator of cyclin-dependent kinase 5 , 1994, Nature.
[50] L. Tsai,et al. p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.
[51] J. Habener,et al. Signal transduction crosstalk in the endocrine system: pancreatic beta-cells and the glucose competence concept. , 1992, Trends in biochemical sciences.
[52] D. Kelley,et al. Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.
[53] K. Polonsky,et al. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.
[54] S. O’Rahilly,et al. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. , 1988, The New England journal of medicine.